VEGFA and neoplasm: For instance, Avastin (bevacizumab), a recombinant antibody targeting VEGF/VEGFR signaling in tumor microenvironment, has been approved by the Food and Drug Administration (FDA) for the treatment of certain women with the advanced OC [15].